Correlation Between Transcode Therapeutics and Pharmather Holdings

Can any of the company-specific risk be diversified away by investing in both Transcode Therapeutics and Pharmather Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Transcode Therapeutics and Pharmather Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Transcode Therapeutics and Pharmather Holdings, you can compare the effects of market volatilities on Transcode Therapeutics and Pharmather Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Transcode Therapeutics with a short position of Pharmather Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Transcode Therapeutics and Pharmather Holdings.

Diversification Opportunities for Transcode Therapeutics and Pharmather Holdings

-0.14

Correlation Coefficient

Transcode Therapeutics  Pharmather Holdings

Good diversification

The 3 months correlation between Transcode and Pharmather is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Transcode Therapeutics and Pharmather Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmather Holdings and Transcode Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Transcode Therapeutics are associated (or correlated) with Pharmather Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmather Holdings has no effect on the direction of Transcode Therapeutics i.e., Transcode Therapeutics and Pharmather Holdings go up and down completely randomly.

Pair Corralation between Transcode Therapeutics and Pharmather Holdings

Given the investment horizon of 90 days Transcode Therapeutics is expected to under-perform the Pharmather Holdings. In addition to that, Transcode Therapeutics is 3.13 times more volatile than Pharmather Holdings. It trades about -0.1 of its total potential returns per unit of risk. Pharmather Holdings is currently generating about 0.03 per unit of volatility. If you would invest  16.00  in Pharmather Holdings on December 30, 2024 and sell it today you would earn a total of  0.00  from holding Pharmather Holdings or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Transcode Therapeutics  vs.  Pharmather Holdings

Transcode Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Transcode Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pharmather Holdings

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Pharmather Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting basic indicators, Pharmather Holdings may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Transcode Therapeutics and Pharmather Holdings

The main advantage of trading using opposite Transcode Therapeutics and Pharmather Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Transcode Therapeutics position performs unexpectedly, Pharmather Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmather Holdings will offset losses from the drop in Pharmather Holdings' long position.

The idea behind Transcode Therapeutics and Pharmather Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.